Showing results (71-80 of 201) with videos related to
Sort By:
Pageof 21
Environmental Research|August 16, 2000
A community-based assessment of heat-related morbidity in North PhiladelphiaJ Mattern, S Garrigan, S B KennedyAnticancer Research|March 1, 1991
Time course of MDR gene amplification during in vivo selection for doxorubicin-resistance and during reversal in murine leukemia L 1210M Volm, J Mattern, E W PommerenkeKlinische Wochenschrift|June 15, 1975
[Testing of the resistance of human tumours in the short-term test (author's transl)]M Volm, M Kaufmann, K Wayss, et al.British Journal of Cancer|August 15, 2002
Protein expression profiles indicative for drug resistance of non-small cell lung cancerM Volm, R Koomägi, J Mattern, et al.International Journal of Oncology|May 17, 2011
Prognostic value of oncoproteins for the survival of patients with nonsmall cell lung carcinomasM Volm, P Drings, J Mattern, et al.International Journal of Oncology|May 5, 2011
Coexpression of cyclin D1 and retinoblastoma gene product (pRb) in human squamous cell lung carcinomas is associated with increased tumor take rate in nude miceM Volm, G Stammler, R Koomagi, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Sequential methotrexate (MTX) and 5-fluorouracil (FU) in human tumor xenograftsK Wayss, R Herrmann, J Mattern, et al.International Journal of Cancer|June 22, 1995
Predictive value of statin, a G0-associated cell cycle protein, in childhood acute lymphoblastic leukemiaM Volm, S Hecker, A Sauerbrey, et al.Anticancer Research|November 1, 1982
Therapeutic response of human lung tumour xenografts to cyclophosphamideJ Mattern, S Jaeger, K Wayss, et al.Carcinogenesis|October 1, 1984
An alternative assay system for the detection of transforming genesR Brown, G Brady, J Mattern, et al.Pageof 21